Fundraising Fox

Dayton Misfeldt

Investor

Partner at Decheng Capital

San Francisco, California, United States

Find your path to Dayton

34 people in our graph share verified history with Dayton — schools, employers, funds. One of them is your warm intro.

Laura TseunlockedDayton: together at Decheng Capital (2021–2023)
×2Dayton: together at Bay City Capital
×9Dayton: together at Decheng Capital

About

Dayton Misfeldt is a Partner at Decheng Capital, which he joined in January 2021. He was previously a Managing Director at Bay City Capital, where he invested in biopharmaceutical companies and supported management teams on strategy, business development, and exits, and earlier worked as a sell-side analyst at Roth Capital Partners and in consulting at LifeScience Economics. He holds a BA in Economics from the University of California, San Diego.

Contact· self-published, not guessed

Invests in

Biotech

Experience

  1. Decheng CapitalPartnercurrent2021 — presentMenlo Park, California, United States
  2. Bay City CapitalPartner2000 — 2020

Skills & more

Venture Capital7Lifesciences5Pharmaceutical Industry6

From Dayton's professional profile.

Investments

Board seats

ExcellergyUpstream Bio

Investor

Cadence PharmaceuticalsCivitas TherapeuticsDermiraExcellergyMAP PharmaceuticalsNextwave PharmaceuticalsOculex PharmaceuticalsPharmion

Per the firm's website.

Colleagues at Decheng Capital

Aaron Li
Principal at Decheng Capital
Claire Zhang
Senior Associate at Decheng Capital
Fengying Yu
Promoter at Decheng Capital
Joan Chen
Vice President at Decheng Capital
Katherine Xu
Partner at Decheng Capital
Michael Notaras
Vice President at Decheng Capital
Min Cui
Founder and Managing Director at Decheng Capital
Nick Pliam
Venture Partner at Decheng Capital

Frequently asked questions

Who is Dayton Misfeldt?
Dayton Misfeldt is a Partner at Decheng Capital, which he joined in January 2021. He was previously a Managing Director at Bay City Capital, where he invested in biopharmaceutical companies and supported management teams on strategy, business development, and exits, and earlier worked as a sell-side analyst at Roth Capital Partners and in consulting at LifeScience Economics. He holds a BA in Economics from the University of California, San Diego.
Where does Dayton Misfeldt work?
Dayton Misfeldt is Partner at Decheng Capital.
What does Dayton Misfeldt invest in?
Dayton Misfeldt invests in Biotech.
What boards does Dayton Misfeldt sit on?
Dayton Misfeldt holds tracked board seats at Excellergy, Upstream Bio.
What companies has Dayton Misfeldt invested in?
Investments tracked here include Cadence Pharmaceuticals, Civitas Therapeutics, Dermira, Excellergy, MAP Pharmaceuticals, Nextwave Pharmaceuticals, Oculex Pharmaceuticals, Pharmion.
Where did Dayton Misfeldt go to school?
Dayton Misfeldt studied at UC San Diego.

Same school

Also attended UC San Diego578

Elad GilSolo general partner investing through Gil CapitalMark SusterManaging Partner at Upfront VenturesChester NgGeneral Partner at AtomicBirgitteInvestor at InvestinorHouman HaghighiPartner, Business & Corporate Development at Menlo VenturesFreya Svedberg-KeatingInvestor at Medicxi

+ 572 more

Shared employers

Also worked at Bay City Capital14

Min CuiFounder and Managing Director at Decheng CapitalVictor Tong, Jr.Managing Director at Decheng CapitalNick PliamVenture Partner at Decheng CapitalAndy SchwabManaging Partner at 5AM VenturesLily ChoiInvestor at Vector CapitalFred CravesManaging Director at Bay City Capital

+ 8 more